Mangoni, Arduino - Flinders University - Department of Clinical Pharmacology

研究领域

Arginine metabolomics in health and disease Novel DDAH inhibitors as therapeutic agents in models of neurodegeneration Cardiovascular toxicity of NSAIDs Pharmacoepidemiology of antimuscarinic drugs and adverse effects in older patients

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Dawson, J., Dedigama, M., Elliot, D.J., Sorich, M., Mangoni, A.A. and Rowland, A. (2016). Prolonged induction of warfarin metabolism and a paradoxical INR response in a mitral valve replacement patient receiving rifampicin for infective endocarditis. Biomedical Research and Clinical Practice, 1(2) pp. 62-65. [10.15761/BRCP.1000112] Mangoni, A.A. (2016). Repurposing Niacin as Antiplatelet Drug. Current Clinical Pharmacology, 11(1) pp. 2-3. [10.2174/157488471101160204113351] [Scopus] Mangoni, A.A., Woodman, R.J., Kichenadasse, G., Rowland, A. and Sorich, M. (2016). Anti-VEGF-induced hypertension and cancer outcomes: translating research into clinical practice. Expert Review of Precision Medicine and Drug Development, 1(2) pp. 12 5-127. [10.1080/23808993.2016.1155963] Mallarkey, G. and Mangoni, A. (2015). Targeting precision medicine toxicity: recent developments. Therapeutic Advances in Drug Safety, 6(1) pp. 4-14. [10.1177/2042098614560737] Kemp, L., Mangoni, A. and Woodman, R. (2014). Online survey on subjective and objective competency in clinical pharmacology skills among final year Australian medical students: a pilot study. Therapeutic Advances in Chronic Disease, 5(6) pp. 274-279. [10.1177/2040622314547361] [Scopus] Mangoni, A. (2014). Geriatric medicine in an aging society: up for a challenge? Frontiers in Medicine, 1(10) [10.3389/fmed.2014.00010] [10.3389/fmed.2014.00010] [Web Link] Mangoni, A. (2014). Harmonization in Pharmacoepidemiological Studies: (Twi)Light at the End of the Tunnel? Current Clinical Pharmacology, 9(2) pp. 91-92. [10.2174/1574884709666140403120834] [Scopus] Woodman, R. and Mangoni, A.A. (2013). Adjusting for brachial artery diameter in the analysis of flow-mediated dilatation: Pitfalls of a landmark paper? Atherosclerosis, 228(1) pp. 277-279. [10.1016/j.atherosclerosis.2013.01.005] [Scopus] Almalag, H., Mangoni, A.A. and Crilly, M. (2012). Methotrexate and risk of cardiovascular disease. American Journal of Cardiology, 109(9) pp. 1383-1384. [10.1016/j.amjcard.2012.01.374] [Scopus] Mallarkey, G. and Mangoni, A.A. (2012). Latest drug safety alerts from the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Therapeutic Advances in Drug Safety, 3(1) pp. 5-11. [10.1177/2042098611424178] [Scopus] Mangoni, A.A. and Woodman, R. (2011). Homocysteine and cardiovascular risk: An old foe creeps bac. Journal of The American College of Cardiology, 58(10) pp. 1034-1035. [10.1016/j.jacc.2011.05.029] [Scopus] Mallarkey, G. and Mangoni, A. (2010). Pharmacovigilance and pharmacogenetic discussions at WorldPharma 2010. Therapeutic Advances in Drug Safety, 1(1) pp. 7-10. [10.1177/2042098610383791] Woodman, R. and Mangoni, A. (2010). Is the Aldosterone:Renin Ratio Truly Reproducible? Hypertension, 55 pp. e18. [10.1161/HYPERTENSIONAHA.110.149799] [Scopus] Mangoni, A. (2010). Editorial. Therapeutic Advances in Drug Safety, 1(1) pp. 5-6. [10.1177/2042098610381527] Baughman, C., Spurling, L. and Mangoni, A.A. (2008). Provision of warfarin education to hospital inpatients. British Journal of Clinical Pharmacology, 66(3) pp. 416-417. [10.1111/j.1365-2125.2008.03242.x] [Scopus] Knights, K.M., Mangoni, A.A. and Miners, J.O. (2007). Authors' reply: Nonselective nonsteroidal anti-inflammatory drugs and increased cardiovascular events: emotional stress could be the explanation. British Journal of Clinical Pharmacology, 63(4) pp. 502-502. [10.1111/j.1365-2125.2006.02788.x] [Scopus] Mangoni, A.A. (2007). The impact of advancing age on P-glycoprotein expression and activity: current knowledge and future directions. Expert Opinion on Drug Metabolism and Toxicology, 3(3) pp. 315-320. [10.1517/17425255.3.3.315] [Scopus] Lu, T.Y., Kupa, A., Easterbrook, G. and Mangoni, A.A. (2005). Profound wight loss associated with reboxetine use in a 44-year-old woman. British Journal of Clinical Pharmacology, 60(2) pp. 218-220. [10.1111/j.1365-2125.2005.02407.x] [Scopus] Jackson, S.H., Mangoni, A.A. and Batty, G.M. (2004). Optimization of drug prescribing. British Journal of Clinical Pharmacology, 57(3) pp. 231-236. [10.1046/j.1365-2125.2003.02018.x] [Scopus] Mangoni, A.A. (2004). Diastolic and pulse pressure: the old and the new? Hypertension, 43(3) pp. 531-532. [10.1161/01.HYP.0000117154.80362.39] [Scopus]